<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2022-3400</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-3400</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БИОБАНКИРОВАНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BIOBANKING</subject></subj-group></article-categories><title-group><article-title>Управление рисками в биобанкировании</article-title><trans-title-group xml:lang="en"><trans-title>Risk management in biobanking</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4020-6647</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Борисова</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Borisova</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Борисова Анна Львовна — ведущий инженер лаборатории "Банк биологического материала"</p><p>Москва</p><p>SPIN-код 7454-8504</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">a.borisova0108@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6985-7131</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Покровская</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Pokrovskaya</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Покровская Мария Сергеевна — кандидат биологических наук, ведущий научный сотрудник, руководитель лаборатории "Банк биологического материала"</p><p>Москва</p><p>SPIN-код 2886-6605</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">mpokrovskaya@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5989-6233</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мешков</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Meshkov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мешков Алексей Николаевич — доктор медицинских наук, руководитель лаборатории "Молекулярной генетики"</p><p>Москва</p><p>SPIN-код 6340-5187</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">meshkov@lipidclinic.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2062-1536</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Концевая</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kontsevaya</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Концевая Анна Васильевна — доктор медицинских наук, доцент, заместитель директора по научной и аналитической работе</p><p>Москва</p><p>SPIN-код 6787-2500</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">AKontsevaya@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Драпкина Оксана Михайловна — доктор медицинских наук, профессор, академик РАН, директор</p><p>Москва</p><p>SPIN-код 4456-1297</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">Drapkina@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>09</month><year>2022</year></pub-date><volume>21</volume><issue>11</issue><fpage>3400</fpage><lpage>3400</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Борисова А.Л., Покровская М.С., Мешков А.Н., Концевая А.В., Драпкина О.М., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Борисова А.Л., Покровская М.С., Мешков А.Н., Концевая А.В., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Borisova A.L., Pokrovskaya M.S., Meshkov A.N., Kontsevaya A.V., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/3400">https://cardiovascular.elpub.ru/jour/article/view/3400</self-uri><abstract><p>Менеджмент рисков является одним из ключевых аспектов организации и  управления работой биобанков и  представляет собой часть общей системы менеджмента качества, направленной на своевременное выявление, анализ и минимизацию событий, которые способны повлечь за собой негативные последствия для биобанка, а также повлиять на качество биообразцов и ассоциированных с ними данных. В статье представлена классификация рисков процесса биобанкирования с описанием каждой категории.</p><sec><title>Цель</title><p>Цель. Разработка и  внедрение в  биобанке ФГБУ "НМИЦ ТПМ" Минздрава России (далее — НМИЦ ТПМ) методологии идентификации, анализа, оценки и разработки мероприятий по управлению рисками процесса биобанкирования.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Приведена методология процесса управления рисками, разработанная на основе литературных данных, мирового опыта и опыта биобанка НМИЦ ТПМ.</p></sec><sec><title>Результаты</title><p>Результаты. Процедура управления рисками процесса биобанкирования разработана и  внедрена в  биобанке НМИЦ ТПМ в  2020г. Проведенная работа позволила выявить, проанализировать и оценить широкий круг потенциальных негативных событий и действий, способных повлечь за собой потери для биобанка как с точки зрения финансовых убытков, так и с позиции этических и технических вопросов, связанных с процессом биобанкирования. Значительное снижение частоты аварийных событий и высокая устойчивость работы биобанка в условиях воздействия различных внешних факторов доказывают эффективность применяемого подхода.</p></sec><sec><title>Заключение</title><p>Заключение. Создание и  поддержание в  биобанке НМИЦ ТПМ системы управления рисками позволяет в  комплексе с  другими мерами обеспечить безопасность и  высокое качество процедур сбора, обработки и долгосрочного хранения биоматериала и ассоциированных с  ним данных путем создания среды, исключающей или минимизирующей воздействие рисков различных категорий на работу биобанка.</p></sec></abstract><trans-abstract xml:lang="en"><p>Risk management is a key aspect of the organization and management of biobanks, which is part of the overall quality management system aimed at early detection, analysis and minimization of events, that can lead to negative consequences for the biobank, as well as affect the quality of biosamples and related data. The article presents the biobanking risk classification with the description of each category.</p><sec><title>Aim</title><p>Aim. To develop and implement the methodology for identification, analysis, evaluation and development of risk management measures for the biobanking process in the biobank of the National Medical Research Center for Therapy and Preventive Medicine.</p></sec><sec><title>Material and methods</title><p>Material and methods. We present the methodology of the risk management process developed on the basis of the literary data, world experience and experience of the biobank of the National Medical Research Center for Therapy and Preventive Medicine.</p></sec><sec><title>Results</title><p>Results. The biobanking risk management procedure was developed and implemented in the biobank of the National Medical Research Center for Therapy and Preventive Medicine in 2020. The work carried out made it possible to identify, analyze and evaluate a wide range of potential negative events and actions that could lead to biobank damage, both in the form of financial losses and ethical and technical issues related to the biobanking process. A significant reduction in the frequency of emergency events and the high stability of the biobank operation under the influence of various external factors prove the effectiveness of the approach used.</p></sec><sec><title>Conclusion</title><p>Conclusion. The creation and maintenance of a risk management system in the biobank allows, in combination with other measures, to ensure the safety and high quality of the procedures for collecting, processing and long-term storage of biomaterial and related data by creating an environment that rules out or minimizes the impact of various risks.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>биобанк</kwd><kwd>биобанкирование</kwd><kwd>управление рисками</kwd><kwd>управление качеством</kwd><kwd>система менеджмента качества биобанка</kwd><kwd>риски</kwd></kwd-group><kwd-group xml:lang="en"><kwd>biobank</kwd><kwd>biobanking</kwd><kwd>risk management</kwd><kwd>quality management</kwd><kwd>biobank quality management system</kwd><kwd>risks</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Simeon-Dubach D, Zaayenga A, Henderson MK. Disaster and recovery: the importance of risk assessment and contingency planning for biobanks. Biopreserv Biobank. 2013;11(3):133-4. doi:10.1089/bio.2013.1131.</mixed-citation><mixed-citation xml:lang="en">Simeon-Dubach D, Zaayenga A, Henderson MK. Disaster and recovery: the importance of risk assessment and contingency planning for biobanks. Biopreserv Biobank. 2013;11(3):133-4. doi:10.1089/bio.2013.1131.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sargsyan K, Jaksa B, Hartl G, Macheiner T. Risk Management in Biobanks. In: Risk Management and Assessment. Ed., Rocha J. London: IntechOpen, 2020:1-32. ISBN: 978-1-83880-796-2.</mixed-citation><mixed-citation xml:lang="en">Sargsyan K, Jaksa B, Hartl G, Macheiner T. Risk Management in Biobanks. In: Risk Management and Assessment. Ed., Rocha J. London: IntechOpen, 2020:1-32. ISBN: 978-1-83880-796-2.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bledsoe MJ. Ethical Legal and Social Issues of Biobanking: Past, Present, and Future. Biopreserv Biobank. 2017;15(2):142-7. doi:10.1089/bio.2017.0030.</mixed-citation><mixed-citation xml:lang="en">Bledsoe MJ. Ethical Legal and Social Issues of Biobanking: Past, Present, and Future. Biopreserv Biobank. 2017;15(2):142-7. doi:10.1089/bio.2017.0030.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kasperbauer TJ, Gjerris M, Waldemar G, Sandøe P. Communicating Identifiability Risks to Biobank Donors. Camb Q Healthc Ethics. 2018;27(1):123-36. doi:10.1017/S0963180117000457.</mixed-citation><mixed-citation xml:lang="en">Kasperbauer TJ, Gjerris M, Waldemar G, Sandøe P. Communicating Identifiability Risks to Biobank Donors. Camb Q Healthc Ethics. 2018;27(1):123-36. doi:10.1017/S0963180117000457.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nusbaum L, Douglas B, Damus K, et al. Communicating Risks and Benefits in Informed Consent for Research: A Qualitative Study. Glob Qual Nurs Res. 2017;4:2333393617732017. doi:10.1177/2333393617732017.</mixed-citation><mixed-citation xml:lang="en">Nusbaum L, Douglas B, Damus K, et al. Communicating Risks and Benefits in Informed Consent for Research: A Qualitative Study. Glob Qual Nurs Res. 2017;4:2333393617732017. doi:10.1177/2333393617732017.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rychnovská D. Anticipatory Governance in Biobanking: Security and Risk Management in Digital Health. Sci Eng Ethics. 2021;27(3):30. doi:10.1007/s11948-021-00305-w.</mixed-citation><mixed-citation xml:lang="en">Rychnovská D. Anticipatory Governance in Biobanking: Security and Risk Management in Digital Health. Sci Eng Ethics. 2021;27(3):30. doi:10.1007/s11948-021-00305-w.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Eder J, Gottweis H, Zatloukal K. IT solutions for privacy protection in biobanking. Public Health Genom. 2012;15(5):254-62. doi:10.1159/000336663.</mixed-citation><mixed-citation xml:lang="en">Eder J, Gottweis H, Zatloukal K. IT solutions for privacy protection in biobanking. Public Health Genom. 2012;15(5):254-62. doi:10.1159/000336663.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zika E, Schulte In den Bäumen T, Kaye J, et al. Sample, data use and protection in biobanking in Europe: legal issues. Pharmacogenomics. 2008;9(6):773-81. doi:10.2217/14622416.9.6.773.</mixed-citation><mixed-citation xml:lang="en">Zika E, Schulte In den Bäumen T, Kaye J, et al. Sample, data use and protection in biobanking in Europe: legal issues. Pharmacogenomics. 2008;9(6):773-81. doi:10.2217/14622416.9.6.773.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Goisauf M, Martin G, Bentzen HB, et al. Data in question: A survey of European biobank professionals on ethical, legal and societal challenges of biobank research. PLoS One. 2019;14(9):e0221496. doi:10.1371/journal.pone.0221496.</mixed-citation><mixed-citation xml:lang="en">Goisauf M, Martin G, Bentzen HB, et al. Data in question: A survey of European biobank professionals on ethical, legal and societal challenges of biobank research. PLoS One. 2019;14(9):e0221496. doi:10.1371/journal.pone.0221496.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Биобанкирование. Национальное руководство. Анисимов С.В., Ахмеров Т.М., Балановский О.П. и др.; Национальная ассоциация биобанков и специалистов по биобанкированию. Москва: ООО "Издательство ТРИУМФ", 2022:132-53. 308 с. ISBN: 978-5-93673-322-2.</mixed-citation><mixed-citation xml:lang="en">Biobanking. National guidelines. Anisimov SV, Akhmerov TM, Balanovsky OP, et al. National association of biobanks and biobanking specialists. Moscow: ООО "Triumph", 2022:132-53. 308 р. (In Russ.) ISBN: 978-5-93673-322-2.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Seneviratne V, Bae S, Jeon SB, et al. Development of Temperature Monitoring System of Hospital Cold Storages Based on Wireless Network and its Database Management. J Med Syst. 2021;45(4):44. doi:10.1007/s10916-021-01711-0.</mixed-citation><mixed-citation xml:lang="en">Seneviratne V, Bae S, Jeon SB, et al. Development of Temperature Monitoring System of Hospital Cold Storages Based on Wireless Network and its Database Management. J Med Syst. 2021;45(4):44. doi:10.1007/s10916-021-01711-0.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Roswall N, Halkjær J, Overvad K, et al. Measures taken to restore the Danish Diet, Cancer and Health Biobank after flooding: a framework for future biobank restorations. Biopreserv Biobank. 2013;11(4):206-10. doi:10.1089/bio.2013.0029.</mixed-citation><mixed-citation xml:lang="en">Roswall N, Halkjær J, Overvad K, et al. Measures taken to restore the Danish Diet, Cancer and Health Biobank after flooding: a framework for future biobank restorations. Biopreserv Biobank. 2013;11(4):206-10. doi:10.1089/bio.2013.0029.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Akyüz K, Chassang G, Goisauf M, et al. Biobanking and risk assessment: a comprehensive typology of risks for an adaptive risk governance. Life Sci Soc Policy. 2021;17(1):10. doi:10.1186/s40504-021-00117-7.</mixed-citation><mixed-citation xml:lang="en">Akyüz K, Chassang G, Goisauf M, et al. Biobanking and risk assessment: a comprehensive typology of risks for an adaptive risk governance. Life Sci Soc Policy. 2021;17(1):10. doi:10.1186/s40504-021-00117-7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Борисова А. Л., Покровская М. С., Мешков А. Н. Стандарт по биобанкированию ISO 20387. Анализ требований и опыт внедрения. Клиническая лабораторная диагностика. 2020;65(9):587-92. doi:10.18821/0869-2084-2020-65-9-587-592.</mixed-citation><mixed-citation xml:lang="en">Borisova AL, Pokrovskaya MS, Meshkov AN, et al. ISO 20387 biobanking standard. Analysis of requirements and experience of implementation. Klinicheskaya Laboratornaya Diagnostika [Russian Clinical Laboratory Diagnostics]. 2020;65(9):587-92. (In Russ.) doi:10.18821/0869-2084-2020-65-9-587-592.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ciaburri M, Napolitano M, Bravo E. Business Planning in Biobanking: How to Implement a Tool for Sustainability. Biopreserv Biobank. 2017;15(1):46-56. doi:10.1089/bio.2016.0045.</mixed-citation><mixed-citation xml:lang="en">Ciaburri M, Napolitano M, Bravo E. Business Planning in Biobanking: How to Implement a Tool for Sustainability. Biopreserv Biobank. 2017;15(1):46-56. doi:10.1089/bio.2016.0045.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Новожилов Е. О. Принцип построения матриц рисков. Надежность. 2015;(3): 73-86. doi:10.21683/1729-2646-2015-0-3-73-86.</mixed-citation><mixed-citation xml:lang="en">Novozhilov EO. Guidelines for construction of a risk matrix. Dependability. 2015;(3):73-86. (In Russ.) doi:10.21683/1729-2646-2015-0-3-73-86.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Parry-Jones A, Hansen J, Simeon-Dubach D, et al. Crisis Management for Biobanks. Biopreserv Biobank. 2017;15(3):253- 63. doi:10.1089/bio.2016.0048.</mixed-citation><mixed-citation xml:lang="en">Parry-Jones A, Hansen J, Simeon-Dubach D, et al. Crisis Management for Biobanks. Biopreserv Biobank. 2017;15(3):253- 63. doi:10.1089/bio.2016.0048.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Покровская М. С., Борисова А. Л., Сивакова О.В. и др. Управление качеством в биобанке. Мировые тенденции и опыт ФГБУ "НМИЦ профилактической медицины" Минздрава России. Клиническая лабораторная диагностика. 2019;64(6):380-4. doi:10.18821/0869-2084-2019-64-6-380-384.</mixed-citation><mixed-citation xml:lang="en">Pokrovskaya MS, Borisova AL, Sivakova OV, et al. Quality management in biobank. World tendencies and experience of biobank of FSI "NMRC for preventive medicine" of the Ministry of healthcare of Russia. Klinicheskaya Laboratornaya Diagnostika [Russian Clinical Laboratory Diagnostics]. 2019;64(6):380-4. (In Russ.) doi:10.18821/0869-2084-2019-64-6-380-384.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
